FDA.reportPublic FDA data

insulin lispro 100 UNT/ML in 3 ML Pen Injector

RxCUI
1652639
RxNorm name
insulin lispro 100 UNT/ML in 3 ML Pen Injector
Display name
insulin lispro 100 UNT/ML in 3 ML Pen Injector
Full name
insulin lispro 100 UNT/ML in 3 ML Pen Injector
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:20

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
020563Humaloginsulin lispro351(a)Rx2026-07-01
205747Humaloginsulin lispro351(a)Rx2026-07-01
209196Admeloginsulin lispro351(a)Rx2026-07-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 6 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Humalog KwikPenINSULIN LISPROEli Lilly and Companyc8ecbd7a-0e22-4fc7-a503-faa58c1b6f3f2026-01-09Warnings, Adverse reactionsExact identifier
rxcui: 1652639
ADMELOGINSULIN LISPROREMEDYREPACK INC.12ec9e3f-e2ac-43a1-b334-8b6538cf2bb02025-10-01Warnings, Adverse reactionsExact identifier
rxcui: 1652639
Insulin LisproINSULIN LISPROEli Lilly and Company97d5e596-aae1-42c9-ae89-c3780959c4672025-06-17Warnings, Adverse reactionsExact identifier
rxcui: 1652639
ADMELOGINSULIN LISPROSanofi-Aventis U.S. LLC0691def8-4a7b-4de3-866f-a280989f47f12025-06-04Warnings, Adverse reactionsExact identifier
rxcui: 1652639
HUMALOGINSULIN LISPROA-S Medication Solutionsc6b8ff07-d3e2-457f-8a38-b60de60adf752025-04-01Warnings, Adverse reactionsExact identifier
rxcui: 1652639
Humalog KwikPenINSULIN LISPROA-S Medication Solutions51d3dc11-52b9-4296-a2f4-58c770d4448d2024-01-24Warnings, Adverse reactionsExact identifier
rxcui: 1652639

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 7 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
c8ecbd7a-0e22-4fc7-a503-faa58c1b6f3finsulin lispro 100 UNT/ML in 3 ML Pen Injector [PSN] · 3 ML insulin lispro 100 UNT/ML Pen Injector [SCD] · insulin lispro 100 UNT/ML per 3 ML Pen Injector [SY]386These highlights do not include all the information needed to use HUMALOG safely and effectively. See full prescribing information for HUMALOG. HUMALOG (insulin lispro) injection, for subcutaneous or intravenous use Initial U.S. Approval: 199620260109
c6b8ff07-d3e2-457f-8a38-b60de60adf75insulin lispro 100 UNT/ML in 3 ML Pen Injector [PSN] · 3 ML insulin lispro 100 UNT/ML Pen Injector [SCD] · insulin lispro 100 UNT/ML per 3 ML Pen Injector [SY]324These highlights do not include all the information needed to use HUMALOG safely and effectively. See full prescribing information for HUMALOG. HUMALOG (insulin lispro) injection, for subcutaneous or intravenous use Initial U.S. Approval: 199620250401
0691def8-4a7b-4de3-866f-a280989f47f1insulin lispro 100 UNT/ML in 3 ML Pen Injector [PSN] · 3 ML insulin lispro 100 UNT/ML Pen Injector [SCD] · insulin lispro 100 UNT/ML per 3 ML Pen Injector [SY]314These highlights do not include all the information needed to use ADMELOG safely and effectively. See full prescribing information for ADMELOG ® . ADMELOG (insulin lispro) injection, for subcutaneous or intravenous use Initial U.S. Approval: 201720250604
97d5e596-aae1-42c9-ae89-c3780959c467insulin lispro 100 UNT/ML in 3 ML Pen Injector [PSN] · 3 ML insulin lispro 100 UNT/ML Pen Injector [SCD] · insulin lispro 100 UNT/ML per 3 ML Pen Injector [SY]312These highlights do not include all the information needed to use INSULIN LISPRO safely and effectively. See full prescribing information for INSULIN LISPRO. INSULIN LISPRO injection, for subcutaneous or intravenous use Initial U.S. Approval: 1996 This product is HUMALOG ® (insulin lispro).20250617
51d3dc11-52b9-4296-a2f4-58c770d4448dinsulin lispro 100 UNT/ML in 3 ML Pen Injector [PSN] · 3 ML insulin lispro 100 UNT/ML Pen Injector [SCD] · insulin lispro 100 UNT/ML per 3 ML Pen Injector [SY]37These highlights do not include all the information needed to use HUMALOG safely and effectively. See full prescribing information for HUMALOG. HUMALOG (insulin lispro) injection, for subcutaneous or intravenous use Initial U.S. Approval: 199620240124
12ec9e3f-e2ac-43a1-b334-8b6538cf2bb0insulin lispro 100 UNT/ML in 3 ML Pen Injector [PSN] · 3 ML insulin lispro 100 UNT/ML Pen Injector [SCD] · insulin lispro 100 UNT/ML per 3 ML Pen Injector [SY]33These highlights do not include all the information needed to use ADMELOG safely and effectively. See full prescribing information for ADMELOG ® . ADMELOG (insulin lispro) injection, for subcutaneous or intravenous use Initial U.S. Approval: 201720251001
ce8354f4-bf07-4923-8755-47f3163662e4insulin lispro 100 UNT/ML in 3 ML Pen Injector [PSN] · 3 ML insulin lispro 100 UNT/ML Pen Injector [SCD] · insulin lispro 100 UNT/ML per 3 ML Pen Injector [SY]33These highlights do not include all the information needed to use HUMALOG safely and effectively. See full prescribing information for HUMALOG. Humalog (insulin lispro injection, USP [rDNA origin]) for injection Initial U.S. Approval: 199620120522